Key facts
- This page summarizes Stanton D. Anderson's Form 4 filing for Physicians Realty Trust.
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 01 Mar 2024, 16:05.
Stanton D. Anderson - 01 Mar 2024 Form 4 Insider Report for Physicians Realty Trust
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 01 Mar 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Mar 2024, 16:05:25 UTC
- Prior SEC filing
- 19 Jul 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher M. Bartoli, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Stanton D. Anderson filed Form 4 for Physicians Realty Trust on 01 Mar 2024.
Change
- Previous filing in this sequence was filed on 19 Jul 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DOC
transaction
Common shares, $0.01 par value
Options Exercise
- Transaction value
- Shares
- +3,360
- Change %
- +8.9%
- Price
- Shares after
- 40,985
- Date
- 01 Mar 2024
- Ownership
- Direct
- Footnotes
- F1, F2
DOC
transaction
Common shares, $0.01 par value
Options Exercise
- Transaction value
- Shares
- +7,483
- Change %
- +18%
- Price
- Shares after
- 48,468
- Date
- 01 Mar 2024
- Ownership
- Direct
- Footnotes
- F1
DOC
transaction
Common shares, $0.01 par value
Disposed to Issuer
- Transaction value
- Shares
- -48,468
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 01 Mar 2024
- Ownership
- Direct
- Footnotes
- F3
DOC
transaction
Common shares, $0.01 par value
Disposed to Issuer
- Transaction value
- Shares
- -25,189
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 01 Mar 2024
- Ownership
- Represents shares held by the Stanton D. Anderson Trust
- Footnotes
- F3, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DOC
transaction
Derivative
2022 Restricted Share Unit Grant
Options Exercise
- Transaction value
- $0
- Shares
- -3,360
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 01 Mar 2024
- Ownership
- Direct
- Underlying class
- Common shares, $0.01 par value
- Underlying amount
- 3,360
- Exercise price
- Footnotes
- F5
DOC
transaction
Derivative
2023 Restricted Share Unit Grant
Options Exercise
- Transaction value
- $0
- Shares
- -7,483
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 01 Mar 2024
- Ownership
- Direct
- Underlying class
- Common shares, $0.01 par value
- Underlying amount
- 7,483
- Exercise price
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Stanton D. Anderson is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 6 footnotes
Footnote F1
Each restricted stock unit represents the right to receive one share of the Issuer's common shares. Represents vesting of the time-based restricted stock units on March 1, 2024 pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") dated October 29, 2023 among the Issuer, Physicians Realty L.P., Healthpeak Properties, Inc. ("Healthpeak"), DOC DR Holdco, LLC and DOC DR LLC. The Issuer merged with and into DOC DR Holdco, LLC on March 1, 2024.
Footnote F2
Includes 585 shares acquired under the Dividend Reinvestment and Share Purchase Plan and 6,265 shares transferred to the Stanton D. Anderson Trust.
Footnote F3
Represents securities disposed of pursuant to the terms of the the Merger Agreement and each issued and outstanding common shares of the Issuer, held by the reporting person was automatically converted into the right to receive 0.674 of a share of Healthpeak common stock, subject to any adjustment, without interest.
Footnote F4
Includes shares transferred from the Reporting Person.
Footnote F5
On March 1, 2022, the Reporting Person was granted 6,720 restricted stock units, which vest in two equal installments on March 1, 2023 and March 1, 2024, subject to the terms of the grant. The grant vested on March 1, 2024 pursuant to the terms of the Merger Agreement.
Footnote F6
On March 1, 2023, the Reporting Person was granted 7,483 restricted stock units, which vest in two equal installments on March 1, 2024 and March 1, 2025, subject to the terms of the grant. The grant vested on March 1, 2024 pursuant to the terms of the Merger Agreement.